$0.58
arrow_drop_down3.33%Key Stats | |
---|---|
Open | $0.58 |
Prev. Close | $0.60 |
EPS | -1.64 |
Dividend | Non-Dividend |
Next Earnings Date | - |
Dividend Yield % | - |
Market Cap | $7.04M |
PE Ratio | - |
LOW | HIGH | |
---|---|---|
Day Range | 0.58 | 0.60 |
52 Week Range | 0.33 | 4.90 |
Ratios | |
---|---|
EPS | -1.64 |
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Period: Next 12 Months
•Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Kineta, Inc Transitioning from Nasdaq to OTC Markets
Kineta Reopens Enrollment for the VISTA-101 Clinical Trial Evaluating KVA12123 in Patients with Advanced Solid Tumor Cancer
VISTA Inhibitor Clinical Trials Drug Approval Insight - GlobeNewswire
Kineta Reports First Quarter 2024 Financial Results and Provides Update on its Ongoing Phase 1/2 VISTA-101 Clinical Trial and Corporate Activities
Why Medical Properties Trust Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
Why Ascent Solar Technologies Shares Are Trading Lower By Around 50%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session